
Beximco Pharmaceuticals Investor Relations Material
Latest events

H1 24/25
28 Jan, 2025

Q1 24/25
15 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beximco Pharmaceuticals PLC
Access all reports
Beximco Pharmaceuticals Limited, also known as Beximco Pharma, is a prominent pharmaceutical company based in Bangladesh, part of the Bangladesh Export Import Company Limited (BEXIMCO). Established in 1980, Beximco Pharma has grown to manufacture and market its own branded generics for various diseases including AIDS, cancer, asthma, hypertension, and diabetes, catering to both national and international markets. It holds the distinction of being the first drug company from Bangladesh to sell its products in the US market. The company operates out of its headquarters in Dhanmondi, Dhaka, Bangladesh, and its shares are listed on the Dhaka Stock Exchange and the London Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BXP
Country
🇬🇧 United Kingdom